Drug-induced decrease of protein kinase A activity reveals alteration in BDNF expression of bipolar affective disorder

Neuropsychopharmacology

Volumn 29, Issue 4, 2004, Pages 805-812

  Karege, Félicien ^a   Schwald, Michèle ^a   El Kouaissi, Rachid ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

BDNF; Bipolar affective disorder; cAMP dependent PKA; Lymphoblast Sp 8 Br cAMPS and Rp 8 Br cAMPS

Indexed keywords

8 BROMO CYCLIC AMP; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; PROTEIN KINASE C ALPHA;

ANTIBODY LABELING; ARTICLE; BIPOLAR DISORDER; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOMER; LYMPHOBLAST; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN TARGETING; UPREGULATION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ACTIVATING TRANSCRIPTION FACTOR 1; ADULT; BIPOLAR DISORDER; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; PROTEIN SUBUNITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 1642488348     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300384     Document Type: Article

References (47)

1. Bezchlibnyk Y, Young LT (2002). The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression. Can J Psychiatry 47: 135-148.
2. Chang A, Li PP, Warsh JJ (2003). Altered cAMP-dependent protein kinase subunit immunolabeling in postmortem brain from patients with bipolar affective disorder. J Neurochem 84: 781-791.
3. Chen B, Dowlatshahi D, MacQueen GM, Wang J-F, Young LT (2001). Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50: 260-265.
4. Condorelli DF, Dell'Albani P, Mudo G, Timmusk T, Belluardo N (1994). Expression of neurotrophins and their receptors in primary astroglyal cultures: induction by cAMP-elevating agents. J Neurochem 63: 509-516.
5. Dowlatshahi D, MacQueen GM, Wang J-F, Reiach JS, Young T (1999). G protein-coupled cAMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 73: 1121-1126.
6. Duman RS (2002). Synaptic plasticity and mood disorders. Mol Psychiatry 7: S29-S34.
7. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597-605.
8. Dwivedi Y, Rao JS, Rizavi HS, Kotowski J, Conley RR, Roberts RC et al (2003a). Abnormal expression and functional characteristics of cAMP response element binding in protein brain of suicide subjects. Arch Gen Psychiatry 60: 273-282.
9. Dwivedi Y, Rizavi HS, Conley RR, Tamminga CA, Pandey GN (2003b). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60: 804-815.
10. Emamghoreishi M, LI PP, Schlichter L, Sugar V, Parikh SV, Cooke R et al (2000). Associated disturbances in calcium homeostasis and G-protein-mediated cAMP signaling in bipolar I disorder. Biol Psychiatry 48: 665-673.
11. Fields A, Li PP, Kish SJ, Warsh JJ (1999). Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder. J Neurochem 73: 1704-1710.
12. Finkbeiner S, Tavazoe SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME (1997). CREB: a major mediator of neuronal neurotrophin responses. Neuron 19: 1031-1047.
13. Francis SH, Corbin JD (1999). Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit Rev Clin Lab Sci 36: 275-328.
14. Ghosh A, Carnahan J, Greenberg ME (1994). Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263: 1618-1623.
15. Gjerstsen BT, Mellgren G, Otten A, Maronde E, Geneeser HG, Jastorff B et al (1995). Novel(Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. J Biol Chem 270: 20599-20607.
16. Goodwin FK, Jamison KR (1990). Manic-depressive Illness. Oxford University Press: New York.
17. Karege F, Perrez G, Bondolfi G, Schwald M, Bertschy G, Aubry J-M (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109: 143-148.
18. Karege F, Schwald M, Lambercy C, Murama JJ, Cissé M, Malafosse A (2001). A non radioactive assay for the cAMP-dependent protein kinase activity in rat brain homogenates and age-related changes in hippocampus and cortex. Brain Res 903: 86-93.
19. Karege F, Schwald M, Papadimitriou P, Lachausse C, Cissé C (2003). The cAMP-dependent protein kinase A and brain-derived neurotrophic factor expression in lymphoblast cells of bipolar affective disorder. J Affect Disord, print copy in press (originally published online Jan. 31, 2003, at www.sciencedir ect.com/science).
20. Kay G, Sargeant M, McGuffin P, Whatley S, Marchbanks R, Bullok T et al (1994). The lymphoblast β-adrenergic receptor in bipolar depressed patients: effects of chronic incubation with lithium chloride. J Affect Disord 30: 185-192.
21. Li PP, Andreopoulos A, Warsh JJ (2000). Signal transduction abnormalities in bipolar affective disorder. In: Cerebral Signal Transduction: From First to Fourth messengers, MEA Reith (ed) Human Press: Totowa. pp 283-309.
22. Manji HK, Moore GJ, Rajkowska G, Chen G (2000). Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 5: 578-593.
23. Mayrs B, Montminy M (2001). Transcriptional regulation by the phosphorylation-dependent factor CREM. Nat Rev Mol Cell Biol 2: 599-609.
24. Morinobu S, Fujimaki K, Okuyuma N, Takahashi M, Duman RS (1999). Stimulation of adenylyl cyclase and induction of brain-derived neurotrophic factor and trk B mRNA by NKH477, a novel and potent forskolin derivative. J Neurochem 72: 2198-2205.
25. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN et al (2000). Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470: 113-117.
26. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy L (2002). The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71: 651-655.
27. Perez J, Tardito D, Mori S, Racagni G, Smeraldi E, Zanardi R (1999). Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. Arch Gen Psychiatry 56: 248-253.
28. Perez J, Tardito D, Smeraldi E, Racagni G, Zanardi R (2001). Protein kinase A and Rap 1 levels in platelets of untreated patients with major depression. Mol Psychiatry 6: 44-49.
29. Perez J, Zanardi R, Mori S, Gasperini M, Smeraldi E, Racagni G (1995). Abnormalities of cAMP-dependent endogenous phosphorylation in platelets from patients with bipolar disorder. Am J Psychiatry 152: 1204-1206.
30. Rajkowska G (2000). Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48: 766-777.
31. Roceri M, Hendriks W, Ricagni G, Ellbroek BA, Riva MA 2002. Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Mol Psychiatry 7: 609-616.
32. Romppanen EL, Savolainen K, Mononen I (2000). Optimal use of the fluorescent PicoGreen dye for quantitative analysis of amplified polymerase chain reaction products on microplate. Anal Biochem 279: 111-114.
33. Schaap P, van Mentes-Cohen M, Soede RDM, Brandt R, Firtel RA, Dostmann W et al (1993). Cell-permeable non hydrolyzable cAMP derivatives as tools for analysis of signaling pathways controlling gene regulation in Dictystelium. J Biol Chem 268: 6323-6331.
34. Schenone A, Gill JS, Zacharias DA, Windbank AJ (1996). Expression of high and low neurotrophin receptors on human transformed B lymphocytes. J Neuroimmunol 64: 141-149.
35. Shamir A, Ebstein RP, Nemanov L, Zohar A, Belmaker RH, Agam G (1998). Inositol monophosphate in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy. Mol Psychiatry 3: 381-382.
36. Shelton RC, Manier DH, Sulzer F (1996). cAMP-dependent protein kinase activity in major depression. Am J Psychiatry 153: 1037-1042.
37. Shieh PB, Ghosh A (1999). Molecular mechanisms underlying cAMP activity-dependent regulation of BDNF expression. J Neurobiol 41: 127-134.
38. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C et al (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54: 70-75.
39. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22: 3251-3261.
40. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G et al (2002). Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 7: 579-593.
41. Spaulding SW (1993). The ways in which hormones change cyclic adenosine 3′,5′ monophosphate-dependent protein kinase subunits and how such changes affect cell behavior. Endocr Rev 14: 632-650.
42. Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT (2001). Abnormalities in the cAMP signaling pathway in postmortem brain tissue from the Stanley neuropathology consortium. Brain Res Bull 55: 625-629.
43. Tardito D, Mori S, Racagni G, Smeraldi E, Zanardi R, Perez J (2003). Protein kinase A activity in platelets from patients with bipolar disorder. J Affect Disord 76: 249-253.
44. Tardito D, Tura GB, Bocchio L, Bognotti S, Piolo L, Racagni G et al (2000). Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients. Neuropsychopharmacology 23: 216-219.
45. Walls FE, Henkel RD, Stern MP, Jenson HB, Moyer MP (1995). An efficient method for routine Epstein-Barr virus immortalization of human B lymphocytes. In Vitro Cell Dev Biol Anim 31: 156-159.
46. Wright AF, Crichton DN, Loudon JB, Morten JE, Steel CM (1984). Adrenoceptor defects in cell lines from families with manicdepressive disorder. Ann Hum Genet 48: 201-214.
47. Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykiewicz O et al (1993). Cerebral cortex Gαs protein levels and forskolin-stimulated cAMP formation are increased in bipolar affective disorder. J Neurochem 61: 890-898.